Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesImmunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 06/15/09
Nikitakis NG et al. - The data indicate an almost universal expression of activated Stat3 and survivin in benign and malignant SGTs. Considering the well established proliferative and antiapoptotic properties of these molecules and their functional interrelationship, selective targeting techniques against Stat3 and/or survivin may represent promising therapeutic strategies against neoplasms of salivary gland origin.
Today in Salivary Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09
Sclerosing mucoepidermoid carcinoma of the parotid gland: Case report
ENT Journal, 11/20/09
Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer
Head & Neck, 11/13/09
Article Search
Sponsor